Consistent with our in vitro data, CPX treatment dramatically decreased the protein expression of both PCNA and Ki-67, which are cell proliferation markers48, in the tumor sections of xenograft model of CRC compared with vehicle treatment (control group). The gene discussed is MKI67; the disease is colorectal carcinoma.